Janus Henderson Group PLC Sarepta Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.31 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.15 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$550 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$527 Million0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$382 Million6.47% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...